Medical News

RSS

Event to address rheumatoid arthritis

26 men and women with RA from across europe honoured as they share their inspirational stories. Actress, artist and activist Jane Seymour will host the first My Day for RA European event in Barcelona, Spain this evening to recognise the daily challenges, hopes and achievements of people living with rheumatoid arthritis (RA).

22 Sep 2009

Prospect Medical Holdings' shares to be traded on the Nasdaq Global Market

Prospect Medical Holdings, Inc. (NYSE Amex: PZZ) (“Prospect”), which provides quality, coordinated healthcare and physician services in southern California, today announced that, effective September 30, 2009, shares of its common stock are scheduled to move from trading on the NYSE Amex to trading on the Nasdaq Global Market. The stock will continue to trade under the symbol “PZZ.”

22 Sep 2009

Smoking bans result in consistent decline in heart attack rates: Study

A consistent decline in heart attack rates following the implementation of smoking bansStrongly enforced legislation to restrict smoking produces rapid and substantial reductions in community rates of heart attack, according to a meta-analysis published today in Circulation, the journal of the American Heart Association.

22 Sep 2009

National Standards Report on ASD treatments released by National Autism Center

The National Autism Center, a nonprofit organization dedicated to serving individuals with Autism Spectrum Disorders (ASD), today released its National Standards Report, the most comprehensive analysis of treatments for children and adolescents with ASD ever published.

22 Sep 2009

NicOx announces publication of blood pressure results from the phase 3 study of naproxcinod

NicOx S.A. (NYSE Euronext Paris: COX) today announced that an important scientific article has been published in the September issue of the American Journal of Cardiology. The publication describes the blood pressure results from the 301 phase 3 study for naproxcinod in detail. Naproxcinod is the first-in-class Cyclooxygenase-Inhibiting Nitric Oxide Donating (CINOD) anti-inflammatory agent for the relief of the signs and symptoms of osteoarthritis (OA).

22 Sep 2009

Emissary Capital begins investment research coverage on Sinobiopharma

Emissary Capital Group, Inc. has initiated investment research coverage on Sinobiopharma, Inc. (OTC Bulletin Board: SNBP) with a Buy rating and target price of $1.00-$1.25.

22 Sep 2009

Taxes from Internet gambling to help fund health care reform

An increased focus on the benefits of Internet gambling regulation are expected as the Senate Finance Committee considers a proposal introduced on Saturday to use Internet gambling revenue to offset the costs of health care reform.

22 Sep 2009

Gerresheimer opens new R&D and production centers in USA and Europe

The Gerresheimer Group expands its activities in the pharmaceutical plastic business with two strategically significant investments in the USA and Europe. This week the company is almost simultaneously opening a new research and development center for medical plastic systems in the USA as well as a new production center for pharmaceutical plastic packaging in Spain.

22 Sep 2009

XRCMI's rapid results imaging tests program

XRC Medical Imaging (XRCMI) has announced a new rapid results program offering feedback directly to patients regarding their imaging tests within 24 hours of their appointments. XRCMI Medical Director Vu Nguyen, M.D., noted that in many cases, patients will actually get their test results before they leave from their appointment. Tests in the rapid results program include diagnostic mammograms, general X-rays and bone density tests, as well as CT and ultrasound scans.

22 Sep 2009

UAB's researchers find early indicators for Alzheimer's disease

Inability to handle financial transactions or manage money may be an early indicator that a person with mild memory problems soon is likely to develop Alzheimer's disease, according to new research from the University of Alabama at Birmingham (UAB) Alzheimer's Disease Center, part of the Department of Neurology.

22 Sep 2009

Drug registration process for Nutra Pharma's pain reliever begins

Nutra Pharma Corp., a biotechnology company that is developing treatments for Adrenomyeloneuropathy (AMN), HIV and Multiple Sclerosis (MS), has announced today that it plans to begin the drug registration process in Canada and Europe for its over-the-counter (OTC) pain reliever. The company is currently marketing a similar drug in the United States under the brand name Cobroxin for the treatment of moderate to severe (Stage 2) chronic pain.

22 Sep 2009

Veterans Healing Initiative formed for veterans suffering from PTSD

The Veterans Healing Initiative (VHI) has been formed in response to the dramatic increase of Substance Abuse (SA) and co-occurring mental health disorders among U.S. Veterans. Formed by Margaret Stone and James L. Abernathy, VHI's core mission is to raise funds for veterans who need treatment for Addiction and Post Traumatic Stress Disorder (PTSD) and help them begin to heal the war within.

22 Sep 2009

Model-Based Design reduces the development time of FES devices

The MathWorks today announced that the Cleveland FES Center, using tools for Model-Based Design, has developed research technology that more quickly restores movement to individuals with neuromuscular disabilities.

22 Sep 2009

ID-ONE Cosmo dual interface card for multiple secure applications launched by Oberthur Technologies

Oberthur Technologies, a global leader in the delivery of high security solutions and the #1 provider of credentials to the U.S. Federal government, announces the availability of its dual interface ID-ONE™ Cosmo card to the Corporate Market at the ASIS International 55th Annual Seminar, September 21-24 at the Anaheim Convention Center in Anaheim, CA.

22 Sep 2009

Interactive Health Insurance Buyer's Guide launched

Today, eHealthInsurance launched a new Interactive Health Insurance Buyer's Guide. Designed for consumers considering all of their options during the traditional open enrollment season, the interactive tool helps consumers make informed decisions when buying their own health coverage.

22 Sep 2009

Late diagnosis of bipolar disorder in children and adults

75% of the cases of paediatric bipolar disorder are diagnosed late - up to 18 months - due to the symptoms manifesting themselves in a different manner depending on whether the patient is a child or adult. Moreover, 25% of sufferers have a delay in their medical diagnoses of up to three years and four months, according to a study by the Department of Psychiatry and Medical Psychology at the University Hospital of Navarra, in collaboration with the Paediatric Psychopharmacology Unit at the l Massachusetts General Hospital at Harvard University (Boston, United States).

22 Sep 2009

Nasdaq issues Repros Therapeutics a second delisting notice

Repros Therapeutics (NasdaqGM:RPRX) today announced that on September 15, 2009, the Company received a second letter from The Nasdaq Stock Market advising that, in addition to the deficiencies previously disclosed on August 17, 2009, the Company’s market value of publicly held shares was below the minimum $15,000,000 requirement for continued listing on the Nasdaq Global Market by Listing Rule 5450(b)(2)(C) or 5450(b)(3)(C).

22 Sep 2009

Amorfix announces 100% specificity upon testing 10,000 blood donations for vCJD

Amorfix Life Sciences, a company focused on treatments and diagnostics for brain wasting diseases, today announced it has achieved 100% specificity (no reproducible false positive results) upon testing 10,000 blood donations for variant Creutzfeldt-Jakob Disease ("vCJD"). with the EP-vCJD(TM) Blood Screening Assay at l'Etablissement Français du Sang de Pyrénées Méditerrannée ("EFS-PM") in Montpellier, France.

22 Sep 2009

PMCC purchases NextGen EHR and EPM software licenses

NextGen Healthcare Information Systems, Inc., a wholly owned subsidiary of Quality Systems, Inc. and a leading provider of ambulatory healthcare and connectivity solutions, today announced that Piedmont Medical Care Corporation (PMCC), the administrative arm of the non-cardiology physician practice entities of Piedmont Healthcare (PHC), has purchased an additional 230 “bundled” NextGen Electronic Health Record (EHR) and NextGen Enterprise Practice Management (EPM) software licenses.

22 Sep 2009

FemSoft from Rochester Medical included in the UK Drug Tariff

Rochester Medical Corporation (Nasdaq: ROCM) today announced that the Company's FemSoft(R) Insert has been approved for inclusion in Part IX of the UK Drug Tariff as a prescription product which is reimbursable.

22 Sep 2009